Cargando…

2364. Surprising Prescribing: Treatment Practices following Addition of Toxin Testing to an Existing Molecular Test for Clostridioides difficile

BACKGROUND: Diagnosis of Clostridioides difficile infection (CDI) is problematic. Adding toxin enzyme immunoassay (EIA) to molecular tests may differentiate disease from colonization and reduce treatment. Detailed descriptions of prescribing patterns following the introduction of EIA testing are not...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Ryan, Morillas, Jose A, Fraser, Thomas G, Brizendine, Kyle D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810074/ http://dx.doi.org/10.1093/ofid/ofz360.2042

Ejemplares similares

2373. Impact of a Change in Testing Strategy for Clostridioides difficile Infection on a Publicly Reported Metric and Treatment Days of Therapy
por: Miller, Ryan, et al.
Publicado: (2019)

2379. It’s Getting Complicated: Outcomes of Clostridiodes difficile PCR Positive/Toxin-Negative Patients
por: Morillas, Jose A, et al.
Publicado: (2019)

COLLABORATION AGREEMENT No. KE2364/TE
por: The European Organization for Nuclear Research, CERN, et al.
Publicado: (2014)

An Update on Clostridioides difficile Binary Toxin
por: Martínez-Meléndez, Adrián, et al.
Publicado: (2022)

Another surprise in receptor binding of C. difficile toxins
por: Aktories, Klaus
Publicado: (2022)

71. Diagnostic Stewardship of Clostridioides difficile Testing
por: Qamar, Zahra, et al.
Publicado: (2021)

839. Effect of Clostridioides difficile (C. difficile) Toxin Test Reporting on Clinical Treatment and Outcomes of Toxin-Negative PCR-Positive Patients at Five California Hospitals
por: Polage, Christopher R, et al.
Publicado: (2019)

677. To Treat or Not To Treat: Patients with Clostridioides difficile PCR-positive/Toxin EIA negative Test Results
por: Yang, Krista, et al.
Publicado: (2023)

The prognostic value of toxin B and binary toxin in Clostridioides difficile infection
por: López-Cárdenas, Salvador, et al.
Publicado: (2021)

2347. Impact of Multidisciplinary Review of Clostridioides difficile Testing
por: Foreman, Jena, et al.
Publicado: (2019)

Host Immune Responses to Clostridioides difficile: Toxins and Beyond
por: Nibbering, Britt, et al.
Publicado: (2021)

Structure and conformational dynamics of Clostridioides difficile toxin A
por: Chen, Baohua, et al.
Publicado: (2022)

Non-Toxin-Based Clostridioides difficile Vaccination Approaches
por: Razim, Agnieszka, et al.
Publicado: (2023)

Diversity of binary toxin positive Clostridioides difficile in Korea
por: Kim, Jieun, et al.
Publicado: (2023)

Clostridioides difficile Toxin B PCR Cycle Threshold as a Predictor of Toxin Testing in Stool Specimens from Hospitalized Adults
por: Lee, Sean, et al.
Publicado: (2022)

1982. A Diagnostic Stewardship Intervention for Clostridioides difficile: Impact of Stool Toxin Testing on Treatment of Adult Inpatients
por: Moss, Jason, et al.
Publicado: (2019)

755. Clostridioides difficile Testing and the Use of Laxatives in Immunocompromised Adults
por: Al-Bahou, Amanda, et al.
Publicado: (2021)

Impact of deoxycholate on Clostridioides difficile growth, toxin production, and sporulation
por: Usui, Yukino, et al.
Publicado: (2020)

The Importance of Therapeutically Targeting the Binary Toxin from Clostridioides difficile
por: Abeyawardhane, Dinendra L., et al.
Publicado: (2021)

Binary Toxin Expression by Clostridioides difficile Is Associated With Worse Disease
por: Young, Mary K, et al.
Publicado: (2022)

Iron Effects on Clostridioides difficile Toxin Production and Antimicrobial Susceptibilities
por: Yamaki, Jason, et al.
Publicado: (2022)

Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced Apoptosis
por: Pike, Colleen M., et al.
Publicado: (2022)

Impact of Two-Step Testing Algorithm on Reducing Hospital-Onset Clostridioides difficile Infections
por: Navalkele, Bhagyashri, et al.
Publicado: (2021)

The cytotoxic synergy between Clostridioides difficile toxin B and proinflammatory cytokines: an unholy alliance favoring the onset of Clostridioides difficile infection and relapses
por: Bassotti, Gabrio, et al.
Publicado: (2020)

Improving Stewardship of Clostridioides difficile Testing with EMR and Provider Phone Calls
por: Joslin, Joseph, et al.
Publicado: (2022)

129. Evaluation of Two-Step Clostridioides difficile Testing on Treatment Exposure
por: Bennett, Nicholas, et al.
Publicado: (2023)

Inhibition of Clostridioides difficile Toxins TcdA and TcdB by Ambroxol
por: Heber, Sebastian, et al.
Publicado: (2022)

Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection
por: Peritore-Galve, F. Christopher, et al.
Publicado: (2022)

Characterization and Pharmacological Inhibition of the Pore-Forming Clostridioides difficile CDTb Toxin
por: Ernst, Katharina, et al.
Publicado: (2021)

Structural Basis for Binding of Neutralizing Antibodies to Clostridioides difficile Binary Toxin
por: Goldsmith, Jory A., et al.
Publicado: (2023)

The TcdE holin drives toxin secretion and virulence in Clostridioides difficile
por: DiBenedetto, NV, et al.
Publicado: (2023)

2356. Increased Clinical Specificity with Ultrasensitive Detection of Clostridioides difficile Toxins: Reduction of Overdiagnosis Compared with Nucleic Acid Amplification Tests
por: Sandlund, Johanna, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in England
por: Bromilow, Tom, et al.
Publicado: (2023)

2399. Ribotype Diversity of Clostridioides difficile strains obtained during screening tests
por: Munoz-Price, L Silvia, et al.
Publicado: (2019)

2361. Evaluation of a 2-Step Testing Algorithm for Clostridioides difficile Infection
por: Zuccaro, Patricia, et al.
Publicado: (2019)

2339. Clostridioides difficile: Impact of Active Screening of Asymptomatic Carriers and Testing Stewardship
por: Beth Graham, Mary, et al.
Publicado: (2019)

104. Evaluation of a 2-Step Testing Algorithm for Clostridioides difficile Infection
por: Bettger, Caitlin C, et al.
Publicado: (2020)

1710. Clostridioides difficile Bundle Implementation Reduces Unnecessary Testing in Pediatric Patients
por: Sietsema, Lydia, et al.
Publicado: (2023)

Expression and (Lacking) Internalization of the Cell Surface Receptors of Clostridioides difficile Toxin B
por: Schöttelndreier, Dennis, et al.
Publicado: (2018)

Metabolic Reprogramming of Clostridioides difficile During the Stationary Phase With the Induction of Toxin Production
por: Hofmann, Julia D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8tms4kqrlj8vv7ff81qje7fo99